itraconazole has been researched along with Apparent Mineralocorticoid Excess Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, BN; Ji, HH; Jia, YT; Liu, Y; Song, L; Tang, XW; Zhang, N | 1 |
| Inderbinen, SG; Kley, M; Odermatt, A; Smieško, M; Zogg, M | 1 |
1 review(s) available for itraconazole and Apparent Mineralocorticoid Excess Syndrome
| Article | Year |
|---|---|
Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Azoles; Child; Humans; Itraconazole; Middle Aged; Mineralocorticoid Excess Syndrome, Apparent; Voriconazole; Young Adult | 2022 |
1 other study(ies) available for itraconazole and Apparent Mineralocorticoid Excess Syndrome
| Article | Year |
|---|---|
Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Itraconazole; Mineralocorticoid Excess Syndrome, Apparent; Protein Conformation; Species Specificity; Structure-Activity Relationship; Triazoles; Zebrafish Proteins | 2021 |